Potential cost-effectiveness of a family-based program in mild Alzheimer's disease patients

European Journal of Health Economics

Volumn 5, Issue 2, 2004, Pages 136-142

  Martikainen, Janne ^a   Valtonen, Hannu ^a   Pirttilä, Tuula ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Alzheimer's disease; Cost effectiveness; Family intervention

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; BAYES THEOREM; CAREGIVER; COGNITION; COST EFFECTIVENESS ANALYSIS; DEGENERATIVE DISEASE; DISEASE COURSE; FAMILY; MONTE CARLO METHOD; PRIORITY JOURNAL; QUALITY OF LIFE;

EID: 3042574850     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10198-003-0214-1     Document Type: Article

References (38)

1. Sulkava R, Wikström J, Aromaa A, Raitasalo R, Lehtinen V, Lahtela K, Palo J (1985) Prevalence of severe dementia in Finland. Neurology 35:1025-1029
2. Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, Hebert LE, Hennekens CH, Taylor JO (1989) Prevalence of Alzheimer's disease in a community population of older persons. JAMA 262:2551-2556
3. Bachman DL, Wolf PA, Linn R, Knoefel JE, Cobb J, Belanger A, D'Agostino RB, White LR (1992) Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham study. Neurology 42:115-119
4. Skoog I, Nilsson L, Palmertz B, Andreasson L-A, Svanborg A (1993) A population-based study of dementia in 85-year-olds. N Engl J Med 328:153-158
5. Ott A, Breteler MMB, Harskamp van F, Claus JJ, Cammen van der TJM, Grobbee DE, Hofman A (1995) Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. BMJ 310:970-973
6. Polvikoski T, Sulkava R, Myllykangas L, Notkola I-L, Niinistö L, Verkkoniemi A, Kainulainen K, Kontula K, Perez-Tur J, Hardy J, Haltia M (2001) Prevalence of Alzheimer's disease in very elderly people. A prospective neuropathological study. Neurology 56:1690-1696
7. Wimo A, Ljunggren G, Winblad B (1997) Costs of dementia and dementia care-a review. Int J Geriatr Psychiatry 12:841-856
8. Hu T, Huang L, Cartwright WS (1986) Evaluation of the costs of caring for the senile demented elderly: a pilot study. Gerontologist 26:158-163
9. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 82:239-259
10. Jost BC, Grossberg GT (1995) The natural history of Alzheimer's disease: a brain bank study. J Am Geriatr Soc 43:1248-1255
11. Knopman D, Schneider L, Davis K, Talwalker S, Smith F, Hoover T, Gracon S (1996) Long-term tacrine treatment: effects on nursing home placement and mortality. Neurology 47:166-177
12. Brodaty H, Gresham M, Luscombe G (1997) The Prince Henry Hospital dementia caregiver training program. Int J Geriatr Psychiatry 12:183-192
13. Eloniemi-Sulkava U, Notkola I-L, Hentinen M, Kivelä S-L, Sivenius J, Sulkava R (2001) Effects of supporting community-living demented patients and their caregivers: a randomized trial. J Am Geriatr Soc 49:1282-1287
14. Mittelman MS, Ferris SH, Shulman E, Steinberg G, Levin B (1996) A family intervention to delay nursing home placement of patients with Alzheimer's disease. JAMA 276:1725-1731
15. Stinnett AA, Paltiel AD (1997) Estimating CE ratios under second-order uncertainty: the mean ratio versus the ratio of means. Med Decis Making 17:483-489
16. Neumann PJ, Hermann RC, Kuntz KM, Araki SS, Duff SB, Leon J, PA Berenbaum PA, Goldman PA, Williams LW, Weinstein MC (1999) Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease. Neurology 52:1138-1145
17. Claxton K, Neumann PJ, Araki S, Weinstein MC (2001) Bayesian value-of-information analysis: an application to a policy model of Alzheimer's disease. Int J Technol Assess Health Care 17:38-55
18. Morris JC (1993) The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43:2412-2414
19. Neumann PJ, Araki SS, Arcelus A, Longo A, Papadopoulos G, Kosik KS, Kuntz KM, Bhattacharjya A (2001) Measuring Alzheimer's disease progression with transition probabilities. Estimates from CERAD. Neurology 57:957-964
20. Neumann PJ, Hermann RC, Weinstein MC (1998) Measuring QALYs in dementia. In: Wimo A, Jonsson B, Karlsson, Winblad B. (eds) Health economics in dementia. Wiley: Sussex, p 359-370
21. Dunkin JJ, Anderson-Hanley C (1998) Dementia caregiver burden: a review of the literature and guidelines for assessment and intervention. Neurology 51:S53-S63
22. Schultz R, Beach SR (1999) Caregiving as a risk factor for mortality: the Caregiver Health Effects Study. JAMA 282:2215-2219
23. Heikkinen K, Hujanen T, Rusama H (2001) Terveydenhuollon yksikkökustannukset Suomessa vuonna 2000. Aiheita 23. National Research and Development Centre for Welfare and Health
24. Briggs A, Sculpher M, Buxton M (1994) Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ 3:95-104
25. Bland JM, Altman DG (1998) Bayesians and frequentists. BMJ 317:1151
26. Briggs AH (1999) A Bayesian approach to stochastic cost-effectiveness analysis. Health Econ 8:257-261
27. Briggs AH (2000) Handling uncertainty in cost-effectiveness models. Pharmacoeconomics 17:479-500
28. Briggs AH, Goeree R, Blackhouse G, O'Brien BJ (2002) Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease. Med Decis Making 22:290-308
29. Glick HA, Briggs AH, Polsky D (2001) Quantifying stochastic uncertainty and presenting results of cost-effectiveness analyses. Expert Rev. Pharmacoecon Outcomes Res 1:25-36
30. Stinnett AA, Mullahy J (1998) Net health benefits: a new framework for the analysis in cost-effectiveness analysis. Med Decis Making 18 [Suppl]:S68-S80
31. Laska EM, Meisner M, Siegel C, Stinnett AA (1998) Ratio-based and net benefit-based approaches to health care resource allocation: proofs of optimality and equivalence. Health Econ 8:171-174
32. Van Hout B, Al MJ, Gordon GS, Rutten FF (1994) Cost, effects and C/E-ratios alongside a clinical trial. Health Econ 3:309-319
33. Bell CM, Araki SS, Neumann PJ (2001) The association between caregivers burden and caregiver health-related quality of life in Alzheimer's disease. Alzheimer Dis Assoc Disord 15:129-136
34. Birks J, Grimley Evans J, lakovidou V, Tsolaki M (2001) Rivastigmine for Alzheimer's disease (Cochrane review). Cochrane Library 4
35. Dooley M, Lamb HM (2000) Donepezil: a review of its use in Alzheimer's disease. Drugs Aging 16:199-226
36. Olin J, Schneider L (2002) Galantamine for Alzheimer's disease (Cochrane review). Cochrane Library, 1
37. Feldman H, Gauthier S, Hecker J, Vellas B, Subbiah P, Whalen E (2001) A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease. Neurology 57:613-620
38. Tariot PN, Solomon PR, Morris JC, Kershaw P, Lilienfeld S, Ding C (2000) A 5-month, randomized, placebo-controlled trial of galantamine in AD. Neurology 54:2269-2276